(LYNCHBURG, Va. – Oct. 27, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Advanced Fuels subsidiary has entered into a multi-year commercial
(TORONTO – Oct. 5, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today that Prodigy Clean Energy, Ltd., Pabineau First Nation and Eel River Bar First Nation have selected its BANR microreactor technology for a Transportable Nuclear Power Plant (TNPP) to be located in Belledune, New Brunswick.
(LYNCHBURG, Va. – Oct. 1, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced the award of a contract totaling approximately $189 million for the manufacture of naval nuclear reactor fuel.
(LYNCHBURG, Va. – Sept. 03, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today a contract award from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) to deliver a conceptual design for the first module of a new Lithium Processing Facility to be constructed at the Y-12 National Security Complex.
(LYNCHBURG, Va. – Aug. 3, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics’ stable medical isotopes business.
(LYNCHBURG, Va. – Aug. 20, 2026) BWX Technologies, Inc. (BWXT) announced today that Suzanne Maddux has been named senior vice president, operations, reporting directly to President and Chief Executive Officer Rex Geveden. This newly created position will support the company’s continued growth in nuclear national security and commercial nuclear power markets.
LYNCHBURG, Va. -BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1.
(LYNCHBURG, Va. – Aug. 3, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics’ stable medical isotopes business.
(LYNCHBURG, Va. – July 6, 2026) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully completed its previously announced acquisition of Precision Components Group, LLC (PCG), including its subsidiaries Precision Custom Components (PCC) and DC Fabricators (DCF). PCG is a U.S. manufacturer of complex, heavy-walled and heat-transfer components. The acquisition expands BWXT’s heavy-manufacturing footprint and enhances the company’s ability to deliver U.S.-made nuclear components for the commercial sector.
(LYNCHBURG, Va. – Feb. 5, 2026) Last May, the Administration issued a series of Executive Orders aimed at strengthening and, in some cases, jump-starting the commercial and national security nuclear industries. Since then, BWX Technologies, Inc. (NYSE: BWXT) has played a vital role in delivering on the goals of those executive orders, including Executive Order 14301, which directed the U.S. Department of Energy (DOE) to establish a reactor pilot program to test three advanced reactor designs by July 4.